Ascentage Pharma Group International AAPG Insider Ownership

NASDAQ AAPG
$16.34 +0.43 (+2.79%)
As of: Oct 21, 2026 · 2:02 PM EDT

Insider Holdings by Owner

3.20Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
3.59%
■0% pp QoQ
Shares Held by Insiders
3.20Mn
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
89.03Mn
89,032,613 shares
Direct Holdings
1.60Mn
Indirect: 1.60Mn
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
2
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Updated

Across the past 12 months, Ascentage Pharma Group International insiders reported no open-market purchases or sales.

Form 4 Holdings

Insiders Holding AAPG

Insiders 2
Shares held 3.20Mn
Of outstanding 3.59%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Dajun Yang Chairman And Ceo 1,193,569 405,280 1,598,849 50.0% 22 May, 2026
2 Yifan Zhai Chief Medical Officer 405,280 1,193,569 1,598,849 50.0% 22 May, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

25 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
21 May, 2026 Yifan Zhai Chief Medical Officer Acquired M 92,746 $0.00 $0 405,280 Direct
21 May, 2026 Dajun Yang Chairman And Ceo Acquired M 95,575 $0.00 $0 1,193,569 Direct
21 May, 2026 Dajun Yang Chairman And Ceo Acquired M 92,746 $0.00 $0 405,280 Indirect
21 May, 2026 Yifan Zhai Chief Medical Officer Acquired M 95,575 $0.00 $0 1,193,569 Indirect
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 103,365 $0.00 $0 103,365 Direct
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 95,575 $0.00 $0 95,575 Direct
21 May, 2026 Dajun Yang Chairman And Ceo Disposed M 95,575 $0.00 $0 0 Direct
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 214,999 $0.00 $0 214,999 Direct
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 214,988 $0.00 $0 214,988 Direct
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 298,195 $0.00 $0 0 Direct
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 103,364 $0.00 $0 103,364 Direct
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 298,194 $0.00 $0 298,194 Direct
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 92,746 $0.00 $0 92,746 Direct
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 103,365 $0.00 $0 103,365 Indirect
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 214,999 $0.00 $0 214,999 Indirect
21 May, 2026 Yifan Zhai Chief Medical Officer Disposed M 92,746 $0.00 $0 0 Direct
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 214,988 $0.00 $0 214,988 Indirect
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 95,575 $0.00 $0 95,575 Indirect
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 103,364 $0.00 $0 103,364 Indirect
21 May, 2026 Yifan Zhai Chief Medical Officer Disposed M 95,575 $0.00 $0 0 Indirect